Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : PFE (Pfizer) How high will it go? -- Ignore unavailable to you. Want to Upgrade?

To: Mick Mørmøny who wrote (3772)	6/29/1998 12:35:00 PM
From: zurdo	Respond to of 9523

Madafas, CNBC regularly seems to put out this kind of manipulative crap...They count on the investing public's poor memory to forget the doggy doo they released earlier, when reality shows them to have been totally misleading a short time later...

To: Mick Mørmøny who wrote (3772)	6/30/1998 11:35:00 AM
From: Ally	Read Replies (1) \| Respond to of 9523

>>NEW YORK, June 29 (Reuters) - Donaldson, Lufkin & Jenrette said Monday that analyst Kent Blair recommended switching from Pfizer Inc. (PFE - news) to Warner-Lambert Co. (WLA - news).<< Isn't this the same firm where an analyst appeared on CNBC and said that PTEK was a "gift" when the stock was at $26. After that appearance, the stock went straight down to $7. Analysts have specific agenda when they make their comments in public. Do they communicate the same views to their priviate clients? I wonder.